Tower Research Capital LLC (TRC) - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 85 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$29,850
+184.7%
27,898
+589.2%
0.00%
Q2 2023$10,485
+55084.2%
4,048
-15.2%
0.00%
-100.0%
Q1 2023$19
+18.8%
4,771
+56.3%
0.00%0.0%
Q4 2022$16
-100.0%
3,052
-46.2%
0.00%0.0%
Q3 2022$74,000
+155.2%
5,674
+154.1%
0.00%0.0%
Q2 2022$29,000
+81.2%
2,233
+120.0%
0.00%
Q1 2022$16,000
+23.1%
1,015
+37.9%
0.00%
Q4 2021$13,000
-90.1%
736
-88.2%
0.00%
-100.0%
Q3 2021$131,000
+138.2%
6,235
+123.2%
0.00%
+200.0%
Q2 2021$55,000
+12.2%
2,793
+64.1%
0.00%0.0%
Q1 2021$49,000
+32.4%
1,702
+37.6%
0.00%0.0%
Q4 2020$37,000
-62.2%
1,237
-80.0%
0.00%0.0%
Q3 2020$98,000
+27.3%
6,190
+58.2%
0.00%
-66.7%
Q2 2020$77,000
+381.2%
3,914
+195.6%
0.00%
+200.0%
Q1 2020$16,0000.0%1,324
+23.5%
0.00%0.0%
Q2 2019$16,0001,0720.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Greenspring Associates, LLC 1,573,357$47,665,00061.89%
RHO CAPITAL PARTNERS INC 3,766,666$114,111,00060.06%
Column Group LLC 15,396,116$466,502,00042.31%
Ponoi II Management, LLC 1,298,908$39,357,00028.68%
Ponoi Management, LLC 1,298,908$39,357,00022.52%
Euclidean Capital LLC 2,083,602$63,133,00013.36%
Aquilo Capital Management, LLC 1,005,534$30,463,0006.33%
Octagon Capital Advisors LP 75,227$2,279,0000.79%
Jasper Ridge Partners, L.P. 308,750$9,354,0000.41%
Point72 Asset Management, L.P. 1,761,157$53,354,0000.26%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders